A Study of Stem Cell and Organoid Core Biorepository

Overview

About this study

The purpose of this study is to create a biorepository at Mayo Clinic of Stem Cells and Organoids as part of Mayo Clinic Core.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

  1.  

Inclusion Criteria:

  • All genders, ages, races, ethnicities will be eligible for participation. This may include employees at Mayo Clinic.
  • The presence or absence of a medical condition/disease will not prohibit enrollment in this study
  • Ability to understand study procedures and to comply with them for the entire length of the study.
  1.  

Exclusion Criteria:

  • Allergy to lidocaine, bupivacaine, and/or epinephrine
  • Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/21/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Charles Howe, Ph.D.

Open for enrollment

Contact information:

Center for Multiple Sclerosis and Autoimmune Neurology

DLCMSANResCoor@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20582924

Mayo Clinic Footer